UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 12.565

Sortiert nach

10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2326-2333

1999

Volltextzugriff (PDF)

13-cis-retinoic acid in myelodysplastic syndromes

Journal of clinical oncology, 1986-08, Vol.4 (8), p.1282-1282

1986

Volltextzugriff (PDF)

13-cis retinoic acid treatment for myelodysplastic syndromes

Journal of clinical oncology, 1986-04, Vol.4 (4), p.589-595

1986

Volltextzugriff (PDF)

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1734-1739

2003

Volltextzugriff (PDF)

[18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2697-2704

2009

Volltextzugriff (PDF)

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3090-3095

2007

Volltextzugriff (PDF)

1997 Update of recommendations for the use of tumor markers in breast and colorectal cancer

Journal of clinical oncology, 1998-02, Vol.16 (2), p.793-795

1998

Volltextzugriff (PDF)

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

Journal of clinical oncology, 1995-03, Vol.13 (3), p.570-574

1995

Volltextzugriff (PDF)

2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia

Journal of clinical oncology, 1992-03, Vol.10 (3), p.364-370

1992

Volltextzugriff (PDF)

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

Journal of clinical oncology, 1992-03, Vol.10 (3), p.371-377

1992

Volltextzugriff (PDF)

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1865-1878

2001

Volltextzugriff (PDF)

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology

Journal of clinical oncology, 2002-06, Vol.20 (12), p.2895-2903

2002

Volltextzugriff (PDF)

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3187-3205

2006

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

3 + 3 not equal to (Rolling) 6

Journal of clinical oncology, 2008-01, Vol.26 (2), p.170-171

2008

Volltextzugriff (PDF)

The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?

Journal of clinical oncology, 2008-06, Vol.26 (18), p.3073-3082

JORDAN, V. Craig

2008

Volltextzugriff (PDF)

The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple Myeloma

Journal of clinical oncology, 2012-02, Vol.30 (4), p.445-452

ANDERSON, Kenneth C

2012

Volltextzugriff (PDF)

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

Journal of clinical oncology, 1991-01, Vol.9 (1), p.85-93

1991

Volltextzugriff (PDF)

The 41st David A. Karnofsky Memorial Award Lecture: Academic Research Worldwide—Quo Vadis?

Journal of clinical oncology, 2014-02, Vol.32 (4), p.347-354

PICCART-GEBHART, Martine J

2014

Volltextzugriff (PDF)

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary

Journal of clinical oncology, 1986-03, Vol.4 (3), p.395-399

1986

Volltextzugriff (PDF)

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer

Journal of clinical oncology, 1987-09, Vol.5 (9), p.1492-1493

1987

Volltextzugriff (PDF)

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study

Journal of clinical oncology, 1987-02, Vol.5 (2), p.272-277

1987

Volltextzugriff (PDF)

5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract

Journal of clinical oncology, 1984-11, Vol.2 (11), p.1245-1248

1984

Volltextzugriff (PDF)

5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (SC19)

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3458-3464

2006

Volltextzugriff (PDF)

1 – 25 von 12.565

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

PublikationsformBücher

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.565)
Mit Volltextzugriff
(12.402)

Publikationsform

Artikel
(12.565)

Sprache

Englisch
(12.565)
Japanisch
(3.020)
Russisch
(72)
Norwegisch
(6)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12.347)
Science & Technology
(12.347)
Humans
(11.643)
Female
(8.097)
Biological And Medical Sciences
(6.639)
Medical Sciences
(6.635)
Middle Aged
(6.595)
Male
(6.303)
Aged
(5.689)
Adult
(5.584)
Tumors
(4.083)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3.746)
Treatment Outcome
(3.330)
Pharmacology. Drug Treatments
(2.194)
Aged, 80 And Over
(2.146)
Antineoplastic Agents
(1.939)
Disease-Free Survival
(1.887)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(1.830)
Original Reports
(1.804)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(12.565)
Journals@Ovid Complete
(12.565)
NUS Single-Journal Subscriptions
(12.565)
MEDLINE
(11.663)
IngentaConnect Journals
(11.143)
Ingenta Connect
(11.143)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial

13-cis-retinoic acid in myelodysplastic syndromes

13-cis retinoic acid treatment for myelodysplastic syndromes

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

[18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group

1997 Update of recommendations for the use of tumor markers in breast and colorectal cancer

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

3 + 3 not equal to (Rolling) 6

3-year invasive disease-free survival (iDFS) of the strategy-based, randomized phase II PHERGain trial evaluating chemotherapy (CT) de-escalation in human epidermal growth factor receptor 2-positive (HER2[+]) early breast cancer (EBC)

The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?

The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple Myeloma

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

The 41st David A. Karnofsky Memorial Award Lecture: Academic Research Worldwide—Quo Vadis?

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study

5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract

5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (SC19)

Aktive Filter

Suchergebnisse filtern